MedTrace Logo

Acceptability Study of Vaginal Films for HIV Prevention

NCT01231763 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 84

Last updated 2011-02-09

No results posted yet for this study

Summary

This study is being done to find out what women would want in a film vaginal product for human immunodeficiency virus (HIV) prevention, especially what it should look like and how to apply it.

The investigators hypothesize that women will prefer a smooth, clear, and rectangular quick-dissolve vaginal film for HIV prevention over a textured, opaque, square quick-dissolve vaginal film.

Conditions

  • HIV Infections
  • Anti-Infective Agents

Interventions

OTHER

No intervention (not applicable)

No intervention (not applicable)

Sponsors & Collaborators

  • Doris Duke Charitable Foundation

    collaborator OTHER

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Sharon Hillier, PhD · University of Pittsburgh

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2011-02-28
Completion
2011-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01231763 on ClinicalTrials.gov